Health insurer stocks fell after the Senate ended the shutdown without extending ACA subsidies, delaying the decision to December and raising premium concerns.
Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew more confident about risk assets amid encouraging signs from Washington that the record-long government shutdown may soon conclude.
Monday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
HCA Healthcare’s third quarter was marked by broad-based growth in patient volumes, improved payer mix, and higher utilization of complex services. Management highlighted the impact of increased Medicaid supplemental payments, particularly from Tennessee, Kansas, and Texas, as a significant factor supporting both revenue and margins. CEO Sam Hazen cited the “broad-based volume growth, improved payer mix, more utilization of complex services and additional revenue from Medicaid supplemental programs” as key drivers. The company also emphasized disciplined cost controls and operational execution, contributing to stronger operating margins compared to last year.
As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the market. While specific daily performance metrics remain unreleased, today's trading likely saw the sector reacting to a
Hospital operator HCA Healthcare (NYSE:HCA) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 9.6% year on year to $19.16 billion. The company’s full-year revenue guidance of $75.75 billion at the midpoint came in 0.9% above analysts’ estimates. Its GAAP profit of $6.96 per share was 22.2% above analysts’ consensus estimates.
Wall Street surged to fresh all-time highs Friday as a softer-than-expected inflation reading strengthened market conviction that the Federal Reserve will cut interest rates by 25 basis points at its Oct. 30 policy meeting.
HCA Healthcare beats Q3 estimates with 9.6% revenue growth and higher earnings, raising its 2025 guidance on strong patient volume and stable conditions.
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
HCA Healthcare beats Q3 2025 earnings estimates, reporting strong revenue and EPS. The company also raised its full-year guidance, boosting investor confidence.
Hospital operator HCA Healthcare (NYSE:HCA) announced better-than-expected revenue in Q3 CY2025, with sales up 9.6% year on year to $19.16 billion. The company’s full-year revenue guidance of $75.75 billion at the midpoint came in 0.9% above analysts’ estimates. Its GAAP profit of $6.96 per share was 22.2% above analysts’ consensus estimates.
